Log in or Sign up for Free to view tailored content for your specialty!
Cardiometabolic Disorders News
Sleep and hypertension: A two-way street of risks
BOSTON — Data show sleep abnormalities are associated with hypertension; however, antihypertensive medications can in turn disrupt sleep, complicating treatment for patients, according to a speaker.
Obesity odds more than twice as high for women than men in low- and middle-income nations
Women living in low- and middle-income countries have a higher prevalence of obesity and other cardiometabolic disorders than men, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology Consult: GLP-1 receptor agonists for weight loss management
Obesity is one of the most common chronic preventable comorbidities affecting adults and children in the United States.
Testosterone replacement does not improve steatotic liver disease for older men
Twelve months of testosterone replacement therapy did not improve metabolic dysfunction-associated steatotic liver disease in a group of older men with hypogonadism, according to a secondary analysis of the T Trials.
To improve health outcomes, ask patients about income, food access, housing
BOSTON — Patients struggling to meet cardiometabolic treatment targets may benefit from an assessment of social determinants of health, which could reveal food, housing or financial insecurity issues that play a large role in their health.
People with Bardet-Biedl syndrome lower metabolic syndrome score with setmelanotide
DALLAS — Setmelanotide may lower the risk for metabolic syndrome for people with a rare monogenic form of obesity, according to data presented at ObesityWeek.
VIDEO: Low-dose colchicine can address residual inflammatory risk
BOSTON — In this Healio video exclusive, Paul M. Ridker, MD, MPH, discusses the use of low-dose colchicine to target inflammation in patients who remain at high CVD risk despite controlled LDL.
After many failed trials, novel therapeutics may finally tackle high triglycerides
BOSTON — After years of failed clinical trials with agents to lower severely elevated triglycerides, emerging therapeutics hold promise for effectively addressing hypertriglyceridemia and reducing associated CV risks, a speaker reported.
Prioritize, optimize sleep to reap cardiometabolic benefits
BOSTON — Simple steps to optimize poor sleep habits can translate to large gains in cardiometabolic health, including improvements in BP, insulin resistance and even appetite regulation, according to a speaker.
Home blood pressure measurements ‘missed opportunity’ to tackle CV risk
BOSTON — Out-of-office BP measurements provide the clearest picture of CV risk for patients and are the ideal method to diagnose and treat hypertension, yet most clinicians still rely on inaccurate clinic readings, according to a speaker.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read